Interaction between mutant ataxin-1 and PQBP-1 affects transcription and cell death

Neuron

Volumn 34, Issue 5, 2002, Pages 701-713

  Okazawa, Hitoshi ^a   Rich, Tina ^e   Chang, Alex ^f   Lin, Xi ^g   Waragai, Masaaki ^a   Kajikawa, Masunori ^b   Enokido, Yasushi ^c   Komuro, Akihiko ^d   Kato, Seishi ^d   Shibata, Masao ^b   Hatanaka, Hiroshi ^c   Mouradian, M Maral ^h   Sudol, Marius ^f   Kanazawa, Ichiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Medical & Biological Laboratories Co Ltd   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^g BAYLOR COLLEGE OF MEDICINE   (United States)

^h NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLYGLUTAMINE; RNA POLYMERASE II;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOASSAY; CARBOXY TERMINAL SEQUENCE; CELL DEATH; CELL LINE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MOUSE; MUTANT; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN ISOLATION; SEQUENCE HOMOLOGY; SPINOCEREBELLAR DEGENERATION; TRANSCRIPTION REGULATION;

EID: 18444403420     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6273(02)00697-9     Document Type: Article

References (56)

1. Identification and characterization of the gene causing type 1 spinocerebellar ataxia
2. + encodes a functionally conserved polypeptide essential for mitosis
3. Abberant interaction of transcriptional repressor proteins with the Huntington's disease gene product, huntingtin
4. Evidence for proteasome involvement in polyglutamine disease: Localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro
5. Rsp5 WW domains interact directly with the carboxyl-terminal domain of RNA polymerase II
6. Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1
7. Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice
8. Identification and characterization of an ataxin-1-interacting protein: A1Up, a ubiquitin-like nuclear protein
9. Formation of neuronal intranuclear inclusions underlies the neuropathological dysfunction in mice transgenic for HD mutation
10. Regulation of expanded polyglutamine protein aggregation and nuclear localization by the glucocorticoid receptor
11. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain
12. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei
13. Identification of genes that modify ataxin-1-induced neurodegeneration
14. Assembly of the nuclear transcription and processing machinery: Cajal bodies (coiled bodies) and transcriptosomes
15. Spinocerebellar ataxia type 1 with multiple system degeneration and glial cytoplasmic inclusions
16. Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract
17. RNA polymerase II and the integration of nuclear events
18. The linkage of Kennedy's neuron disease to ARA24, the first identified androgen receptor polyglutamine region-associated coactivator
19. Genomic organization and alternative transcripts of the human PQBP-1 gene
20. Insoluble detergent-resistant aggregates form between pathological and non-pathological lengths of polyglutamine in mammalian cells
21. Ataxin-1 nuclear localization and aggregation: Role in polyglutamine-induced disease in SCA1 transgenic mice
22. Caspase-3 cleaves the expanded androgen receptor protein of spinal and bulbar muscular atrophy in a polyglutamine repeat length-dependent manner
23. A neurological disease caused by an expanded CAG trinucleotide repeat in the TATA binding protein gene: A new polyglutamine disease?
24. Npw38, a novel protein possessing a WW domain capable of activating basal transcription
25. Association of two nuclear proteins, Npw38 and NpwBP, via the interaction between WW domain and a novel proline-rich motif containing glycine and arginine
26. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy
27. Polyglutamine expansion down-regulates specific neuronal genes before pathologic changes in SCA1
28. Polyglutamines, nuclear inclusions and neurodegeneration
29. CREB-binding protein sequestration by expanded polyglutamine
30. Influence by huntingtin and atrophin-1 with CBP-mediated transcription leading to cellular toxicity
31. A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells
32. Bcl-2 inhibits retinoic acid-induced apoptosis during the neural differentiation of embryonic stem cells
33. 1A dopamine receptor gene transcription by Brn-4
34. PQBP-1 (Np/pq): A polyglutamine tract-binding and nuclear inclusion-forming protein
35. Inhibition of caspase-1 slows disease progression in a mouse model of Huntingtin's disease
36. Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1
37. Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3
38. Identification, characterization and crystal structure analysis of the human spliceosamal U5 snRNP-specific 15 kD protein
39. Disassembly of nuclear inclusions in the dividing cell - A novel insight into neurodegeneration
40. Caspase-8 is required for cell death induced by expanded polyglutamine repeats
41. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions
42. Increased apoptosis of huntingtin disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization
43. Expression analysis of the ataxin-1 protein in tissues from normal and spinocerebellar ataxia type 1 individuals
44. A novel protein with RNA-binding motifs interacts with ataxin-2
45. II130, interfering with CREB-dependent transcription
46. The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription
47. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila
48. Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone
49. New wrinkles on the old domain
50. Protein aggregation in Huntington's and Parkinson's disease: Implication for therapy
51. PQBP-1, a novel polyglutamine tract-binding protein, inhibits transcription activation by Brn-2 and affects cell survival
52. PQBP-1/Npw38, a nuclear protein binding to the polyglutamine tract, interacts with U5-15kD/dim1p via the carboxyl-terminal domain
53. NELF, a multisubunit complex containing RD, cooperates with DSIF to repress RNA polymerase II elongation
54. Protein binding of a DRPLA family through arginine-glutamic acid dipeptide repeats is enhanced by extended polyglutamine
55. The spinocerebellar ataxia type 1 protein, ataxin-1, has RNA-binding activity that is inversely affected by the length of its polyglutamine tract
56. Evidence that Dim1 associates with a network of proteins involved in pre-mRNA splicing, and delineation of residues essential for Dim1 interactions with hnRNP F and Npw38/PQBP-1